Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04678583 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer

Study acronym: ARMANI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 32 to 37v9
  2. Primary and study completion dates: Dec 31, 2024 to Dec 2027
    • Study sites: 29 to 32
    v8
  3. Site contacts updated at 1 of 29 sitesv7
  4. Study sites: 22 to 29v6
  5. Study sites: 11 to 22
    • Secondary endpoints: details revised at 1 of 25 entries
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 2 to 11v4
  2. Site details revised at 1 of 2 sitesv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised at 2 of 2 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
the ARMANI trial will test the hypothesis, if an anatomic resection (AR) improves long-term outcome vs. a non-anatomical resection (NAR) in patients undergoing surgery for RAS-mutated colorectal liver metastasis (CRLM).
Trial Details
NCT Number NCT04678583
Lead Sponsor Technische Universität Dresden
Collaborators: German Cancer Research Center
Conditions
(from sponsor)		 Colorectal Liver Metastasis
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov